Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation

Tsung Ming Chen, Yu Heng Shih, Ta-Chien Tseng, Ming Chih Lai, Chih Hao Wu, Yi Han Li, Shaw-Jenq Tsai, Hsiao-Fang Sun

研究成果: Article

15 引文 (Scopus)

摘要

Human fibroblast growth factor 9 (FGF9) is a potent mitogen involved in many physiological processes. Although FGF9 messenger RNA (mRNA) is ubiquitously expressed in embryos, FGF9 protein expression is generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in human malignancies including cancers, but the mechanism remains largely unknown. Here, we report that FGF9 protein, but not mRNA, was increased in hypoxia. Two sequence elements, the upstream open reading frame (uORF) and the internal ribosome entry site (IRES), were identified in the 5' UTR of FGF9 mRNA. Functional assays indicated that FGF9 protein synthesis was normally controlled by uORF-mediated translational repression, which kept the protein at a low level, but was upregulated in response to hypoxia through a switch to IRES-dependent translational control. Our data demonstrate that FGF9 IRES functions as a cellular switch to turn FGF9 protein synthesis 'on' during hypoxia, a likely mechanism underlying FGF9 overexpression in cancer cells. Finally, we provide evidence to show that hypoxia-induced translational activation promotes FGF9 protein expression in colon cancer cells. Altogether, this dynamic working model may provide a new direction in anti-tumor therapies and cancer intervention.

原文English
頁(從 - 到)2932-2944
頁數13
期刊Nucleic acids research
42
發行號5
DOIs
出版狀態Published - 2014 一月 1

指紋

Fibroblast Growth Factor 9
Colonic Neoplasms
Proteins
Neoplasms
Messenger RNA
Open Reading Frames
Hypoxia
Physiological Phenomena
5' Untranslated Regions
Mitogens

All Science Journal Classification (ASJC) codes

  • Genetics

引用此文

Chen, Tsung Ming ; Shih, Yu Heng ; Tseng, Ta-Chien ; Lai, Ming Chih ; Wu, Chih Hao ; Li, Yi Han ; Tsai, Shaw-Jenq ; Sun, Hsiao-Fang. / Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation. 於: Nucleic acids research. 2014 ; 卷 42, 編號 5. 頁 2932-2944.
@article{5aa65bc79e7a4f619045be9c7d874b38,
title = "Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation",
abstract = "Human fibroblast growth factor 9 (FGF9) is a potent mitogen involved in many physiological processes. Although FGF9 messenger RNA (mRNA) is ubiquitously expressed in embryos, FGF9 protein expression is generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in human malignancies including cancers, but the mechanism remains largely unknown. Here, we report that FGF9 protein, but not mRNA, was increased in hypoxia. Two sequence elements, the upstream open reading frame (uORF) and the internal ribosome entry site (IRES), were identified in the 5' UTR of FGF9 mRNA. Functional assays indicated that FGF9 protein synthesis was normally controlled by uORF-mediated translational repression, which kept the protein at a low level, but was upregulated in response to hypoxia through a switch to IRES-dependent translational control. Our data demonstrate that FGF9 IRES functions as a cellular switch to turn FGF9 protein synthesis 'on' during hypoxia, a likely mechanism underlying FGF9 overexpression in cancer cells. Finally, we provide evidence to show that hypoxia-induced translational activation promotes FGF9 protein expression in colon cancer cells. Altogether, this dynamic working model may provide a new direction in anti-tumor therapies and cancer intervention.",
author = "Chen, {Tsung Ming} and Shih, {Yu Heng} and Ta-Chien Tseng and Lai, {Ming Chih} and Wu, {Chih Hao} and Li, {Yi Han} and Shaw-Jenq Tsai and Hsiao-Fang Sun",
year = "2014",
month = "1",
day = "1",
doi = "10.1093/nar/gkt1286",
language = "English",
volume = "42",
pages = "2932--2944",
journal = "Nucleic Acids Research",
issn = "0305-1048",
publisher = "Oxford University Press",
number = "5",

}

Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation. / Chen, Tsung Ming; Shih, Yu Heng; Tseng, Ta-Chien; Lai, Ming Chih; Wu, Chih Hao; Li, Yi Han; Tsai, Shaw-Jenq; Sun, Hsiao-Fang.

於: Nucleic acids research, 卷 42, 編號 5, 01.01.2014, p. 2932-2944.

研究成果: Article

TY - JOUR

T1 - Overexpression of FGF9 in colon cancer cells is mediated by hypoxia-induced translational activation

AU - Chen, Tsung Ming

AU - Shih, Yu Heng

AU - Tseng, Ta-Chien

AU - Lai, Ming Chih

AU - Wu, Chih Hao

AU - Li, Yi Han

AU - Tsai, Shaw-Jenq

AU - Sun, Hsiao-Fang

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Human fibroblast growth factor 9 (FGF9) is a potent mitogen involved in many physiological processes. Although FGF9 messenger RNA (mRNA) is ubiquitously expressed in embryos, FGF9 protein expression is generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in human malignancies including cancers, but the mechanism remains largely unknown. Here, we report that FGF9 protein, but not mRNA, was increased in hypoxia. Two sequence elements, the upstream open reading frame (uORF) and the internal ribosome entry site (IRES), were identified in the 5' UTR of FGF9 mRNA. Functional assays indicated that FGF9 protein synthesis was normally controlled by uORF-mediated translational repression, which kept the protein at a low level, but was upregulated in response to hypoxia through a switch to IRES-dependent translational control. Our data demonstrate that FGF9 IRES functions as a cellular switch to turn FGF9 protein synthesis 'on' during hypoxia, a likely mechanism underlying FGF9 overexpression in cancer cells. Finally, we provide evidence to show that hypoxia-induced translational activation promotes FGF9 protein expression in colon cancer cells. Altogether, this dynamic working model may provide a new direction in anti-tumor therapies and cancer intervention.

AB - Human fibroblast growth factor 9 (FGF9) is a potent mitogen involved in many physiological processes. Although FGF9 messenger RNA (mRNA) is ubiquitously expressed in embryos, FGF9 protein expression is generally low and restricted to a few adult organs. Aberrant expression of FGF9 usually results in human malignancies including cancers, but the mechanism remains largely unknown. Here, we report that FGF9 protein, but not mRNA, was increased in hypoxia. Two sequence elements, the upstream open reading frame (uORF) and the internal ribosome entry site (IRES), were identified in the 5' UTR of FGF9 mRNA. Functional assays indicated that FGF9 protein synthesis was normally controlled by uORF-mediated translational repression, which kept the protein at a low level, but was upregulated in response to hypoxia through a switch to IRES-dependent translational control. Our data demonstrate that FGF9 IRES functions as a cellular switch to turn FGF9 protein synthesis 'on' during hypoxia, a likely mechanism underlying FGF9 overexpression in cancer cells. Finally, we provide evidence to show that hypoxia-induced translational activation promotes FGF9 protein expression in colon cancer cells. Altogether, this dynamic working model may provide a new direction in anti-tumor therapies and cancer intervention.

UR - http://www.scopus.com/inward/record.url?scp=84899006080&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84899006080&partnerID=8YFLogxK

U2 - 10.1093/nar/gkt1286

DO - 10.1093/nar/gkt1286

M3 - Article

C2 - 24334956

AN - SCOPUS:84899006080

VL - 42

SP - 2932

EP - 2944

JO - Nucleic Acids Research

JF - Nucleic Acids Research

SN - 0305-1048

IS - 5

ER -